Whilst small-depend MBL seldom progresses to CLL, significant-count MBL progresses to CLL necessitating therapy in a charge of one% to 2% every year. Higher-rely MBL is distinguished from Rai 0 CLL according to whether or not the B-mobile rely is higher than or beneath five × 109/L. Although m